Professional Documents
Culture Documents
GROUP 1
AURELIÉN BOSSET
ANDREJ NASTEVSKI
MANFREDI SOPRANI
ALBERTO ZAGARELLA
JACOPO ZANARDI
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5 Patients treated: 100,000,
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00% supposed to increase 1%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
per year
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00% Patients expected Market
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1 share: 20%, expected to
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
increase 1% per year in the
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
first 5 years, then stable
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365 Days of treatment per year
Daily Dosage 2 2 2 2 2 2 2 2 2 2 = 365; Daily dosage: 2 pills;
Pills per pack 60 60 60 60 60 60 60 60 60 60
Pills x pack = 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36 Ex Factory Price x pack =
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2% 30€, increasing with an
Weighted Average Commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7% inflation rate of 2%
Discount
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Market Assumptions
Patients Treated 100,000.0 101,000.0 102,010.0 103,030.1 104,060.4 105,101.0 106,152.0 107,213.5 108,285.7 109,368.5
Patients Expected Market Share 20.00% 21.00% 22.00% 23.00% 24.00% 25.00% 25.00% 25.00% 25.00% 25.00%
Patients 20,000.0 21,210.0 22,442.2 23,696.9 24,974.5 26,275.3 26,538.0 26,803.4 27,071.4 27,342.1
Days of Treatment per year 365 365 365 365 365 365 365 365 365 365
Daily Dosage 2 2 2 2 2 2 2 2 2 2
Pills per pack 60 60 60 60 60 60 60 60 60 60
Total Number of Packs per Patient 12 12 12 12 12 12 12 12 12 12
Total Number of Packs per Patient /
243,333 258,055 273,047 288,313 303,856 319,682 322,879 326,108 329,369 332,663
year
Price per pack (€) 30 31 31 32 32 33 34 34 35 36
Inflation rate 2% 2% 2% 2% 2% 2% 2% 2% 2% 2%
Weighted Average Commercial Weighted average commercial
7% 7% 7% 7% 7% 7% 7% 7% 7% 7%
Discount
discount = 7%
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 COGS x pack (including
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
delivery costs) = 9 €,
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
increasing with an inflation
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6) rate of 2%
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% Royalties = 20% of Gross Sales
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0)
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 Yearly Promotional Expenses
Investment Costs (3,500,000.0) (1,000,000.0)
&
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
Reps = 2,000,000 €
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Costs Assumptions
Raw Materials 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39 6.39
Fixed Costs 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50 2.50
COGS x pack adjusted 9.07 9.25 9.44 9.63 9.82 10.01 10.21 10.42 10.63 10.84
Royalties (% of Gross Sales) 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
Royalties per year (1,460,000.0) (1,579,296.6) (1,704,467.1) (1,835,757.6) (1,973,423.4) (2,117,730.0) (2,181,685.5) (2,247,572.4) (2,315,449.1) (2,385,375.6)
Promotional Expenses per year 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0 2,000,000.0
Investment Costs (3,500,000.0) (1,000,000.0) Up-front payment of
D&A 350,000.0 350,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0 475,000.0
3,500,000 € (immediate),
1,000,000 € (third year);
amortization according to the
patent expiration date
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Other Assumptions
1DETERMINISTIC MODEL
(EUR m) 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Sales forecast
Other Assumptions
1DETERMINISTIC MODEL
€5,192,027.7 29.19% 4.82YRS
NPV IRR PAYBACK PERIOD
1DETERMINISTIC MODEL
2STOCHASTIC MODEL
PATIENT STARTING EXPECTED RAW
GROWTH MARKET EXPECTED MATERIALS
GROWTH
RATE SHARE RATE INFLATION COST
Normal distribution Normal distribution Normal distribution Normal distribution Normal distribution
μ=1.06%/year μ=21.72% μ=0.57%/year μ=2.03%/year μ=6.39 EUR
σ=0.87%/year σ=1.25% σ=0.21%/year σ=0.81%/year σ=0.24 EUR
2STOCHASTIC MODEL
DISCOUNT DSO
2STOCHASTIC MODEL
NPV
450
50
0
2.726.798,8 4.691.918,4 6.657.037,9 8.622.157,5 10.587.277,1
2STOCHASTIC MODEL
IRR
450
250 Variance 0%
Minimum 14%
200 Maximum 61%
Range Width 47%
150
Mean Std. Error 0%
100
50
0
19% 27% 35% 43% 51%
2STOCHASTIC MODEL
PAYBACK PERIOD
0,8
0,1
0
2 3 4 5 6
2STOCHASTIC MODEL
3STOCHASTIC MODEL W/
NEW COMPETITOR
New Assumptions :
We decided to create a positive correlation between Market Share Increase and the Weighted Average Commercial
Discount
Correlation Coefficient
= 0.53
We decided to create a custom distribution for every year in which the competitor could enter the market
P = 10 % P = 30 % P = 50 % P = 80 %
Market share decrease due to competitor Market share decrease due to competitor Market share decrease due to competitor Market share decrease due to competitor
Variance 2,759,409,593,561.4
200 Minimum (2,022,610.9)
Maximum 9,277,971.3
150 Range Width 11,300,612.2
Mean Std. Error 11,747.6
100
50
0
(1.504.537,8) 801.848,2 3.108.234,2 5.414.620,2 7.721.006,2
20000
15000
Frequency
5000
0
(1.504.537,8) 801.848,2 3.108.234,2 5.414.620,2 7.721.006,2
450
Statistics: Forecast values
400 Base Case 29%
Mean 26%
350 Median 27%
Standard Deviation 8%
300
Frequency
Variance 1%
250 Minimum -9%
Maximum 53%
200
Range Width 62%
150 Mean Std. Error 0%
100
50
0
4% 15% 26% 37% 48%
20000
15000
Frequency
10000
5000
0
4% 15% 26% 37% 48%
0,1
0
2 3 4 5 6 7 8 9 10 11